We are live on ! Find out more
PI

Putnam Investments Portfolio holdings

AUM $75.7B
1-Year Est. Return 34.45%
This Fund
S&P 500
This Quarter Est. Return
+4.73%
1 Year Est. Return
+34.45%
3 Year Est. Return
+61.95%
5 Year Est. Return
+203.43%
10 Year Est. Return
+402.82%
AUM
$43.9B
AUM Growth
+$967M
Cap. Flow
-$549M
Cap. Flow %
-1.25%
Top 10 Hldgs %
20.89%
Holding
1,275
New
193
Increased
340
Reduced
468
Closed
214

Sector Composition

Rank Sector Weight
1 Technology 16.73%
2 Healthcare 16.25%
3 Financials 15.27%
4 Consumer Discretionary 10.06%
5 Communication Services 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSCO icon
26
Cisco
CSCO
$457B
$327M 0.75%
7,610,821
+2,359,159
+45% +$103M
BSX icon
27
Boston Scientific
BSX
$72B
$327M 0.74%
10,003,513
+1,258,287
+14% +$38M
HLT icon
28
Hilton Worldwide
HLT
$70.7B
$324M 0.74%
4,096,552
+578,425
+16% +$47M
XOM icon
29
ExxonMobil
XOM
$643B
$324M 0.74%
3,915,637
-1,051,473
-21% -$83.8M
AMGN icon
30
Amgen
AMGN
$204B
$318M 0.72%
1,724,050
+31,875
+2% +$5.64M
VLO icon
31
Valero Energy
VLO
$88.5B
$314M 0.71%
2,830,876
+29,161
+1% +$3.27M
META icon
32
Meta Platforms (Facebook)
META
$1.5T
$313M 0.71%
1,613,014
-10,234
-0.6% -$1.85M
MRK icon
33
Merck
MRK
$316B
$304M 0.69%
5,246,083
+497,984
+10% +$28.1M
DXC icon
34
DXC Technology
DXC
$1.78B
$304M 0.69%
3,768,752
-1,046,661
-22% -$90M
MKC icon
35
McCormick & Company Non-Voting
MKC
$13.9B
$298M 0.68%
5,134,844
+978,976
+24% +$51.4M
VRTX icon
36
Vertex Pharmaceuticals
VRTX
$119B
$298M 0.68%
1,751,760
+39,166
+2% +$6.07M
DD icon
37
DuPont de Nemours
DD
$19.1B
$294M 0.67%
1,762,585
+23,214
+1% +$3.89M
ADBE icon
38
Adobe
ADBE
$99.9B
$293M 0.67%
1,203,685
-79,239
-6% -$18.7M
CRM icon
39
Salesforce
CRM
$152B
$293M 0.67%
2,149,938
+198,694
+10% +$25.3M
MRO
40
DELISTED
Marathon Oil Corporation
MRO
$286M 0.65%
13,692,898
-290,334
-2% -$5.72M
CI icon
41
Cigna
CI
$74.5B
$275M 0.63%
1,616,700
+259,280
+19% +$44.9M
GILD icon
42
Gilead Sciences
GILD
$163B
$265M 0.6%
3,746,357
+218,743
+6% +$15.4M
PEP icon
43
PepsiCo
PEP
$191B
$257M 0.59%
2,365,021
+71,090
+3% +$7.34M
T icon
44
AT&T
T
$162B
$253M 0.58%
10,443,385
+534,940
+5% +$13.4M
BLK icon
45
Blackrock
BLK
$175B
$245M 0.56%
491,568
-33,304
-6% -$17.6M
BABA icon
46
Alibaba
BABA
$305B
$242M 0.55%
1,302,237
-179,679
-12% -$34.2M
NSC icon
47
Norfolk Southern
NSC
$75.6B
$241M 0.55%
1,597,000
-778,744
-33% -$114M
PX
48
DELISTED
Praxair Inc
PX
$238M 0.54%
1,506,298
+571,306
+61% +$88.3M
AGO icon
49
Assured Guaranty
AGO
$3.72B
$235M 0.53%
6,578,255
-145,376
-2% -$5.29M
KKR icon
50
KKR & Co
KKR
$95.7B
$235M 0.53%
9,437,050
+1,690,630
+22% +$37.6M

Similar funds

Putnam Investments's Q2 2018 Portfolio in Review

As of Q2 2018, Putnam Investments held 1,275 positions worth $43.9B, up 2.3% from $43B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Putnam Investments's Q2 2018 filing shows 193 new, 340 increased, 468 reduced and 214 closed positions. Its largest new stake was ASML: 323,812 shares worth $64.1M. The largest sale was Jazz Pharmaceuticals, an estimated $371M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • Putnam Investments's largest Q2 2018 buy was ASML: 323,812 shares worth $64.1M.
  • Putnam Investments added most to Walmart Inc in Q2 2018, an estimated $420M increase.
  • Putnam Investments's biggest Q2 2018 reduction was Jazz Pharmaceuticals, cutting an estimated $371M.
  • Putnam Investments fully exited Vodafone in Q2 2018, selling an estimated $84.4M.
  • Putnam Investments's ten largest holdings make up 21% of its $43.9B portfolio in Q2 2018.
  • Putnam Investments opened 193 new positions and closed 214 in Q2 2018.
  • Putnam Investments's portfolio value rose 2.3% quarter-over-quarter to $43.9B.

Based on Putnam Investments's 13F filing for Q2 2018, filed 14 Aug 2018.